Læknaneminn - 01.01.2017, Side 38

Ri
trý
nt
ef
ni
37
14. Stone J, Sharpe M, Binzer M. Motor
conversion symptoms and pseudoseizures:
a comparison of clinical characteristics.
Psychosomatics. 2004;45(6):492­499.
doi:10.1176/appi.psy.45.6.492.
15. Stone J, Warlow C, Sharpe M. The symptom
of functional weakness: A controlled study of
107 patients. Brain. 2010;133(5):1537­1551.
doi:10.1093/brain/awq068.
16. Stone J, Carson A, Sharpe M, Stone J.
Functional symptoms and signs in neurology:
Assessment and diagnosis. J Neurol Neurosurg
Psychiatry. 2005;76:2­12. doi:10.1136/
jnnp.2004.061655.
17. Lempert T, Brandt T, Dieterich M, Huppert
D. How to identify psychogenic disorders of
stance and gait ­ A video study in 37 patients.
J Neurol. 1991;238(3):140­146. doi:10.1007/
BF00319680.
18. Luther JS, McNamara JO, Carwile S, Miller
P, Hope V. Pseudoepileptic seizures: Methods
and video analysis to aid diagnosis. Ann
Neurol. 1982;12(5):458­462. doi:10.1002/
ana.410120508.
19. Slater JD, Brown MC, Jacobs W, Ramsay RE.
Induction of Pseudoseizures with Intravenous
Saline Placebo. Epilepsia. 1995;36(6):580­585.
doi:10.1111/j.1528­1157.1995.tb02571.x.
20. Ricciardi L, Edwards MJ. Treatment of
Functional (Psychogenic) Movement
Disorders. Neurotherapeutics. 2014;11(1):201­
207. doi:10.1007/s13311­013­0246­x.
21. Shamy MCF. The treatment of psychogenic
movement disorders with suggestion
is ethically justified. Mov Disord.
2010;25(3):260­264. doi:10.1002/mds.22911.
22. Stone J, Smyth R, Carson A, Warlow C,
Sharpe M. La belle indifférence in conversion
symptoms and hysteria. Br J Psychiatry.
2006;188(3).
23. Factor SA, Podskalny GD, Molho ES.
Psychogenic movement disorders: frequency,
clinical profile, and characteristics. J Neurol
Neurosurg Psychiatry. 1995;59(4):406­412.
doi:10.1136/jnnp.59.4.406.
24. Portera­Cailliau C, Victor D, Frucht S,
Fahn S. Movement disorders fellowship
training program at Columbia University
Medical Center in 2001­2002. Mov Disord.
2006;21(4):479­485. doi:10.1002/mds.20740.
25. Mehndiratta MM, Kumar M, Nayak R, Garg
H, Pandey S. Hoover’s sign: Clinical relevance
in Neurology. J Postgrad Med. 2014;60(3):297­
299. doi:10.4103/0022­3859.138769.
26. Diukova GM, Ljachovetckaja NI, Begljarova
MA, Gavrileyko GI. Simple quantitative
analysis of Hoover’s test in patients with
psychogenic and organic limb pareses.
J Psychosom Res. 2013;74(4):361­364.
doi:10.1016/j.jpsychores.2012.10.004.
27. Amer M, Hubert G, Sullivan SJ, et al.
Reliability and diagnostic characteristics of
clinical tests of upper limb motor function.
J Clin Neurosci. 2012;19(9):1246­1251.
doi:10.1016/j.jocn.2011.12.007.
28. Stone J, Zeman A, Sharpe M. Functional
weakness and sensory disturbance. J Neurol
Neurosurg Psychiatry. 2002;73(3):241­245.
doi:10.1136/jnnp.73.3.241.
29. Baik JS, Lang AE. Gait abnormalities in
psychogenic movement disorders. Mov Disord.
2007;22(3):395­399. doi:10.1002/mds.21283.
30. Orðabanki Íslenskrar málstöðvar. Íðorðadeild
Íslenskrar málstöðvar. http://www.ordabanki.
hi.is/wordbank/search. Accessed July 21, 2017.
31. van Poppelen D, Saifee TA, Schwingenschuh
P, et al. Attention to self in psychogenic
tremor. Mov Disord. 2011;26(14):2575­2576.
doi:10.1002/mds.23911.
32. Sigurdardottir KR, Olafsson E.
Incidence of psychogenic seizures in
adults: A population­based study in
Iceland. Epilepsia. 1998;39(7):749­752.
doi:10.1111/j.1528­1157.1998.tb01161.x.
33. Mostacci B, Bisulli F, Alvisi L, Licchetta L,
Baruzzi A, Tinuper P. Ictal characteristics
of psychogenic nonepileptic seizures:
What we have learned from video/EEG
recordings—A literature review. Epilepsy
Behav. 2011;22(2):144­153. doi:10.1016/j.
yebeh.2011.07.003.
34. Seneviratne U, Minato E, Paul E. How reliable
is ictal duration to differentiate psychogenic
nonepileptic seizures from epileptic
seizures? Epilepsy Behav. 2017;66:127­131.
doi:10.1016/j.yebeh.2016.10.024.
35. Benbadis SR. A spell in the epilepsy
clinic and a history of “chronic pain” or
“fibromyalgia” independently predict a
diagnosis of psychogenic seizures. Epilepsy
Behav. 2005;6(2):264­265. doi:10.1016/j.
yebeh.2004.12.007.
36. Ettinger AB, Weisbrot DM, Nolan E,
Devinsky O. Postictal symptoms help
distinguish patients with epileptic seizures
from those with non­epileptic seizures.
Seizure. 1999;8(3):149­151. doi:10.1053/
seiz.1999.0270.
37. Stone J, Carson A. Functional neurologic
disorders. Continuum (Minneap Minn).
2015;21(3 Behavioral Neurology and
Neuropsychiatry):818­837. doi:10.1212/01.
CON.0000466669.02477.45.
38. Moene FC, Spinhoven P, Hoogduin KAL, Van
Dyck R. A Randomised Controlled Clinical
Trial on the Additional Effect of Hypnosis in
a Comprehensive Treatment Programme for
In­Patients with Conversion Disorder of the
Motor Type. Psychother Psychosom. 2002;71.
doi:49348.
39. Espay AJ, Goldenhar LM, Voon V, Schrag
A, Burton N, Lang AE. Opinions and
clinical practices related to diagnosing
and managing patients with psychogenic
movement disorders: An international survey
of movement disorder society members. Mov
Disord. 2009;24(9):1366­1374. doi:10.1002/
mds.22618.
40. Carton S, Thompson PJ, Duncan JS. Non­
epileptic seizures: Patients’ understanding
and reaction to the diagnosis and impact
on outcome. Seizure. 2003;12(5):287­294.
doi:10.1016/S1059­1311(02)00290­X.
41. Nielsen G, Stone J, Matthews A, et al.
Physiotherapy for functional motor disorders:
a consensus recommendation. J Neurol
Neurosurg Psychiatry. 2015;86(10):1113­1119.
doi:10.1136/jnnp­2014­309255.
42. Czarnecki K, Thompson JM, Seime R,
Geda YE, Duffy JR, Ahlskog JE. Functional
movement disorders: Successful treatment
with a physical therapy rehabilitation protocol.
Park Relat Disord. 2012;18(3):247­251.
doi:10.1016/j.parkreldis.2011.10.011.
43. Jordbru AA, Smedstad LM, Klungsøyr O,
Martinsen EW. Psychogenic gait disorder:
A randomized controlled trial of physical
rehabilitation with one­year follow­up.
J Rehabil Med. 2014;46(2):181­187.
doi:10.2340/16501977­1246.
44. Goldstein LH, Deale AC, Mitchell­O’Malley
SJ, Toone BK, Mellers JDC. An evaluation of
cognitive behavioral therapy as a treatment for
dissociative seizures: a pilot
study. Cogn Behav Neurol. 2004;17(1):41­49.
doi:10.1097/00146965­200403000­00005.
45. LaFrance WC, Baird GL, Barry JJ, et
al. Multicenter Pilot Treatment Trial
for Psychogenic Nonepileptic Seizures:
A Randomized Clinical Trial. JAMA
psychiatry. 2014;2903(9):1­9. doi:10.1001/
jamapsychiatry.2014.817.
46. Voon V, Lang AE. Antidepressant treatment
outcomes of psychogenic movement disorder.
J Clin Psychiatry. 2005;66(12):1529­1534.
doi:10.4088/JCP.v66n1206.
47. Moene FC, Spinhoven P, Hoogduin CAL,
Van Dyck R, Hoogduin K a L, Van Dyck R.
A randomized controlled clinical trial of a
hypnosis­based treatment for patients with
conversion disorder, motor type. Int J Clin
Exp Hypn. 2003;51(1):29­50. doi:10.1076/
iceh.51.1.29.14067.
48. Carson AJ, Best S, Postma K, Stone J, Warlow
C, Sharpe M. The outcome of neurology
outpatients with medically unexplained
symptoms: a prospective cohort study. J Neurol
Neurosurg Psychiatry. 2003;74(7):897­900.
doi:10.1136/jnnp.74.7.897.
49. Gelauff J, Stone J, Edwards M, Carson A.
The prognosis of functional (psychogenic)
motor symptoms: a systematic review. J Neurol
Neurosurg Psychiatry. 2014;85(2):220­226.
http://jnnp.bmj.com/content/85/2/220.
abstract.
50. Durrant J, Rickards H, Cavanna AE. Prognosis
and outcome predictors in psychogenic
nonepileptic seizures. Epilepsy Res Treat.
2011;2011:274736. doi:10.1155/2011/274736.